**4. Conclusions**

In clinical and preclinical research, there have been a few attempts to integrate throughput screening technologies with precision medicine. The relevance of highthroughput screening approaches in identifying and designing precision therapies for the treatment of various diseases is highlighted in this chapter. Over the last ten years, advances in sequencing technology have enabled several high-throughput sequencing platforms to bring unique insights into the creation of customized medicine. The sequencing technologies of the present day (Ion, Illumina, Torrent, Oxford Nanopore Technologies, pacific biosciences) created a new roadmap for HTS technologies to identify and design precision therapeutics.
